Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT)
ID: 353486Type: Posted
Overview

Buyer

Advanced Research Projects Agency for Health (HHS-ARPAH)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353486

Additional Information

https://sam.gov/opp/0cc6823a822e4416ae2b12d67b548ea5/view
Timeline
    Description

    The Advanced Research Projects Agency for Health (ARPA-H) is offering a funding opportunity for the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program, aimed at advancing innovative solutions in regenerative medicine. This initiative anticipates multiple awards and seeks proposals that align with the program's objectives, with a focus on developing nanotechnology-based tissue solutions. The program is significant for its potential to enhance healthcare outcomes through cutting-edge research and development in science and technology. Interested applicants should note that the proposal due date is August 20, 2024, at 9:00 AM ET, and can contact the PRINT Program Team at PRINT@ARPA-H.gov for further information. Additional details can be found on the SAM.gov posting.

    Point(s) of Contact
    PRINT@ARPA-H.gov
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator- Initiated Studies (UH3 Clincical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies," aimed at advancing research in regenerative medicine utilizing adult stem cells. This initiative, supported by the 21st Century Cures Act, encourages small businesses to develop collaborative projects, although applications are not currently being solicited. The funding will be provided through a cooperative agreement, with an estimated synopsis posting date of August 1, 2025, and a closing date for applications expected by October 21, 2025. For further inquiries, interested parties can contact Aron Marquitz, Ph.D., at aron.marquitz@nih.gov or by phone at 301-435-1240.
    Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening," aimed at developing and validating advanced 3-D tissue models for drug efficacy testing. This initiative seeks to create non-animal models that accurately mimic the physiological properties of human tissues, thereby enhancing the predictive accuracy of drug screening processes. With an estimated total program funding of $1,600,000 and the expectation of awarding two grants, interested applicants are encouraged to utilize the resources available at the NCATS 3-D Bioprinting laboratory. The application process is open to various eligible entities, excluding non-domestic applicants, with a submission deadline anticipated by June 16, 2026. For further inquiries, potential applicants can contact Dobrila D. Rudnicki, Ph.D., at dobrila.rudnicki@nih.gov or by phone at 240-535-6621.
    Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx)" through a cooperative agreement aimed at supporting the development of extramural Resource Centers (RCs) focused on tissue engineering and regenerative medicine (TE/RM). The initiative seeks to foster interdisciplinary translational projects (ITPs) that leverage clinical, scientific, and regulatory expertise to advance therapeutics, diagnostics, and monitoring solutions for tissue damage caused by various health conditions. This funding cycle is particularly significant as it aims to facilitate the validation and preclinical testing of promising TE/RM products, with the goal of achieving regulatory approvals for first-in-human studies. Interested applicants, particularly small businesses with relevant expertise, are encouraged to prepare for future applications, as the estimated synopsis post date is October 7, 2025, with a closing date of November 7, 2025, and an anticipated award date of July 1, 2026. For further inquiries, potential applicants can contact Dr. Scott Verbridge at scott.verbridge@nih.gov or by phone at 301-594-0676.
    NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the NIH Director’s Transformative Research Awards, a federal grant opportunity aimed at supporting innovative and unconventional research projects. This program encourages individual scientists or collaborative teams to propose groundbreaking research that has the potential to redefine scientific paradigms or develop transformative technologies, without the need for preliminary data or detailed experimental plans. With an estimated total funding of $8 million and the expectation of awarding seven grants, interested applicants should prepare their proposals in advance, as applications will be solicited starting June 20, 2025, with a closing date of September 3, 2025. For further inquiries, potential applicants can contact Dr. Patricia Labosky at TransformativeAwards@mail.nih.gov or by phone at 301-594-4863.
    Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)," aimed at enhancing research experiences for resident clinicians in training. This initiative seeks to recruit, retain, and foster the independence of clinician-investigators by providing them with essential research opportunities early in their careers, thereby supporting basic, clinical, and translational research efforts. Although applications are not currently being solicited, potential applicants are encouraged to prepare meaningful collaborations and projects in anticipation of the forthcoming Notice of Funding Opportunity (NOFO). Interested parties can reach out to Dr. David Schopfer at david.schopfer@nih.gov or by phone at 301-402-3833 for further information, with the estimated synopsis posting date on July 11, 2025, and a projected award date of May 1, 2026.
    SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)
    Advanced Research Projects Agency Energy
    The Advanced Research Projects Agency - Energy (ARPA-E) is offering a funding opportunity titled "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)" aimed at supporting innovative energy research and development projects. This grant program encourages the submission of transformative ideas that can lead to significant advancements in energy technologies, with a focus on projects that have the potential to create new learning curves and disrupt existing markets. With an estimated total program funding of $10 million, individual awards can range from $0 to $500,000, and the application process requires registration and submission through the ARPA-E eXCHANGE platform. Interested applicants should note that the application deadline is September 30, 2029, and for further inquiries, they can contact ARPA-E at arpa-e-co@hq.doe.gov.
    Selective Precision Targeting (SPoT)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled Selective Precision Targeting (SPoT) aimed at advancing therapeutic drug delivery systems to specific hard-to-reach locations within the human body. This initiative seeks to optimize the targeting of nanoparticle therapeutics, assess biodistribution and off-target effects, provide evidence of functional cargo activity, and determine the optimal route of administration using microphysiological systems. With an estimated total program funding of $1.5 million and the expectation of awarding five grants, eligible small businesses are encouraged to apply. Interested applicants can reach out to Dr. Passley Hargrove-Grimes at passley.hargrove@nih.gov or by phone at 240-485-4149, with proposals due by February 17, 2026, and project start anticipated on January 18, 2027.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Dental Primary Care Practice-Based Research Network: Administrative and Resource Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of a Dental Primary Care Practice-Based Research Network (PBRN) through a cooperative agreement aimed at creating an Administrative and Resource Center (ARC). The ARC will facilitate the planning and implementation of observational studies and clinical trials focused on integrating oral health care into overall medical care, thereby promoting whole-person health. This initiative is crucial for enhancing research capabilities in dental primary care settings and will involve recruiting practitioners, managing a single Institutional Review Board (IRB), and providing necessary training for study participation across various U.S. regions. Interested applicants can reach out to Dena Fischer at dena.fischer@nih.gov or call 301-594-4876 for further information. The estimated synopsis post date is March 2, 2026, with applications expected to be solicited by May 25, 2026, and the anticipated award date is April 30, 2027.
    Advanced Rehabilitation Research Training (ARRT) Program - Health and Function
    Administration for Community Living
    The Administration for Community Living is offering a grant opportunity through the Advanced Rehabilitation Research Training (ARRT) Program, aimed at enhancing health and function outcomes for individuals with disabilities. This program seeks to provide advanced research training and experience to individuals holding doctorates or similar advanced degrees, with a focus on multidisciplinary disability and rehabilitation research. The grant, which has a funding ceiling of $250,000 and a floor of $245,000, is intended for private and public institutions of higher education, with one award expected to be made for a project period of 36 months. Interested applicants can reach out to Courtney Ward-Sutton at (202) 240-3164 or via email at Courtney.Ward-Sutton@acl.hhs.gov for further details, and must submit their proposals by December 5, 2025.